Re­silience pur­chas­es Ohio bio­man­u­fac­tur­ing site from As­traZeneca

Biotech man­u­fac­tur­ing pi­o­neer Re­silience said Tues­day af­ter­noon that it is pur­chas­ing an Ohio-based man­u­fac­tur­ing site from As­traZeneca and build­ing a new part­ner­ship with the UK …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER